HYCAMTIN O.25 mg
Generic Name: topotecan
Pill imprint HYCAMTIN O.25 mg has been identified as Hycamtin 0.25 mg.
Hycamtin is used in the treatment of cancer; ovarian cancer; cervical cancer; small cell lung cancer and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy.
Hycamtin 0.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Hycamtin Images
- Generic Name:
- topotecan
- Imprint:
-
HYCAMTIN
O.25 mg - Strength:
- 0.25 mg
- Color:
- White
- Size:
- 18.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- glyceryl monostearate
gelatin
titanium dioxide
- Drug Class:
- Miscellaneous antineoplastics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4205
More Hycamtin resources
- Hycamtin (Wolters Kluwer)
- Hycamtin Capsules (Wolters Kluwer)
- Hycamtin (Cerner Multum)
- Hycamtin (Micromedex) - Includes Dosage Information
- Hycamtin Intravenous (Micromedex) - Includes Dosage Information
- Hycamtin (AHFS DI)
- Hycamtin (FDA)


